Evaluation of SGLT-2 inhibitor treatment in type 2 diabetes patients with very high cardiovascular risk

Huberta E. Hart*, Olivier Kievits, Frans H. Rutten, Monika H. Hollander

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

20 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Evaluation of SGLT-2 inhibitor treatment in type 2 diabetes patients with very high cardiovascular risk'. Together they form a unique fingerprint.

Medicine & Life Sciences